Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$0.18 - $0.52 $0 - $0
-1 Reduced 0.63%
157 $0
Q2 2023

Aug 15, 2023

BUY
$0.31 - $0.55 $9 - $16
30 Added 23.44%
158 $0
Q1 2023

May 12, 2023

BUY
$0.32 - $1.88 $3 - $22
12 Added 10.34%
128 $0
Q4 2022

Feb 13, 2023

BUY
$0.35 - $20.75 $1 - $62
3 Added 2.65%
116 $0
Q3 2022

Nov 14, 2022

SELL
$0.83 - $21.25 $5 - $148
-7 Reduced 5.83%
113 $0
Q2 2022

Aug 12, 2022

BUY
$1.12 - $2.18 $10 - $19
9 Added 8.11%
120 $0
Q1 2022

May 16, 2022

SELL
$1.63 - $3.63 $3,256 - $7,252
-1,998 Reduced 94.74%
111 $0
Q3 2021

Nov 15, 2021

BUY
$2.71 - $5.9 $5,571 - $12,130
2,056 Added 3879.25%
2,109 $8,000
Q2 2021

Aug 16, 2021

BUY
$4.83 - $9.67 $140 - $280
29 Added 120.83%
53 $0
Q1 2021

May 13, 2021

BUY
$6.01 - $8.9 $144 - $213
24 New
24 $0

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.